Skip to main content
NCBI home page
Cellular & Molecular Biology Letters logoLink to Cellular & Molecular Biology Letters
. 2008 Oct 31;14(1):153–174. doi: 10.2478/s11658-008-0040-7

Regulator of G-protein signalling expression and function in ovarian cancer cell lines

Jillian H Hurst 1, Nisha Mendpara 1, Shelley B Hooks 1,2,✉
PMCID: PMC6275869  PMID: 18979070

Abstract

Regulator of G-protein signalling (RGS)2 proteins critically regulate signalling cascades initiated by G-protein coupled receptors (GPCRs) by accelerating the deactivation of heterotrimeric G-proteins. Lysophosphatidic acid (LPA) is the predominant growth factor that drives the progression of ovarian cancer by activating specific GPCRs and G-proteins expressed in ovarian cancer cells. We have recently reported that RGS proteins endogenously expressed in SKOV-3 ovarian cancer cells dramatically attenuate LPA stimulated cell signalling. The goal of this study was twofold: first, to identify candidate RGS proteins expressed in SKOV-3 cells that may account for the reported negative regulation of G-protein signalling, and second, to determine if these RGS protein transcripts are differentially expressed among commonly utilized ovarian cancer cell lines and non-cancerous ovarian cell lines. Reverse transcriptase-PCR was performed to determine transcript expression of 22 major RGS subtypes in RNA isolated from SKOV-3, OVCAR-3 and Caov-3 ovarian cancer cell lines and non-cancerous immortalized ovarian surface epithelial (IOSE) cells. Fifteen RGS transcripts were detected in SKOV-3 cell lines. To compare the relative expression levels in these cell lines, quantitative real time RT-PCR was performed on select transcripts. RGS19/GAIP was expressed at similar levels in all four cell lines, while RGS2 transcript was detected at levels slightly lower in ovarian cancer cells as compared to IOSE cells. RGS4 and RGS6 transcripts were expressed at dramatically different levels in ovarian cancer cell lines as compared to IOSE cells. RGS4 transcript was detected in IOSE at levels several thousand fold higher than its expression level in ovarian cancer cells lines, while RGS6 transcript was expressed fivefold higher in SKOV-3 cells as compared to IOSE cells, and over a thousand fold higher in OVCAR-3 and Caov-3 cells as compared to IOSE cells. Functional studies of RGS 2, 6, and 19/GAIP were performed by measuring their effects on LPA stimulated production of inositol phosphates. In COS-7 cells expressing individual exogenous LPA receptors, RGS2 and RSG19/GAIP attenuated signalling initiated by LPA1, LPA2, or LPA3, while RGS6 only inhibited signalling initiated by LPA2 receptors. In SKOV-3 ovarian cancer cells, RGS2 but not RGS6 or RGS19/GAIP, inhibited LPA stimulated inositol phosphate production. In contrast, in CAOV-3 cells RGS19/GAIP strongly attenuated LPA signalling. Thus, multiple RGS proteins are expressed at significantly different levels in cells derived from cancerous and normal ovarian cells and at least two candidate RGS transcripts have been identified to account for the reported regulation of LPA signalling pathways in ovarian cancer cells.

Key words: Regulator of G-protein signalling (RGS) proteins, Ovarian cancer, SKOV-3, OVCAR-3, Caov-3, IOSE, RT-PCR

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Abbreviations used

CT

threshold cycle

ELISA

enzyme-linked immunosorbent assay

GPCR

G-protein coupled receptor

GAPDH

glyceraldehyde-3-phosphate dehydrogenase

GROα

growth-regulated oncogene α

IOSE

immortalized ovarian surface epithelial

IP

inositol phosphates

LPA

lysophosphatidic acid

PLC

phospholipase C

RGS

regulator of G-protein signalling

RT-PCR

reverse transcriptase polymerase chain raction

siRNA

small interfering RNA

References

  • 1.Xu Y., Fang X.J., Casey G., Mills G.B. Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 1995;309:933–940. doi: 10.1042/bj3090933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mills G.B., May C., McGill M., Roifman C.M., Mellors A. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. Cancer Res. 1988;48:1066–1071. [PubMed] [Google Scholar]
  • 3.Frankel A., Mills G.B. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. Clin Cancer Res. 1996;2:1307–1313. [PubMed] [Google Scholar]
  • 4.Sengupta S., Xiao Y.J., Xu Y. A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells. FASEB J. 2003;17:1570–1572. doi: 10.1096/fj.02-1145fje. [DOI] [PubMed] [Google Scholar]
  • 5.Sengupta S., Kim K.S., Berk M.P., Oates R., Escobar P., Belinson J., Li W., Lindner D.J., Williams B., Xu Y. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion. Oncogene. 2007;26:2894–2901. doi: 10.1038/sj.onc.1210093. [DOI] [PubMed] [Google Scholar]
  • 6.Fang X., Gaudette D., Furui T., Mao M., Estrella V., Eder A., Pustilnik T., Sasagawa T., Lapushin R., Yu S., Jaffe R.B., Wiener J.R., Erickson J.R., Mills G.B. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann. N. Y. Acad. Sci. 2000;905:188–208. doi: 10.1111/j.1749-6632.2000.tb06550.x. [DOI] [PubMed] [Google Scholar]
  • 7.Anliker B., Chun J. Lysophospholipid G protein-coupled receptors. J. Biol. Chem. 2004;279:20555–20558. doi: 10.1074/jbc.R400013200. [DOI] [PubMed] [Google Scholar]
  • 8.Noguchi K., Ishii S., Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 2003;278:25600–25606. doi: 10.1074/jbc.M302648200. [DOI] [PubMed] [Google Scholar]
  • 9.Lee C.W., Rivera R., Gardell S., Dubin A.E., Chun J. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J. Biol. Chem. 2006;281:23589–23597. doi: 10.1074/jbc.M603670200. [DOI] [PubMed] [Google Scholar]
  • 10.Oldham, W.M. and H, E.H. Structural basis of function in heterotrimeric G proteins. Q. Rev. Biophys. (2006) 1–50. [DOI] [PubMed]
  • 11.Heximer S.P., Knutsen R.H., Sun X., Kaltenbronn K.M., Rhee M.H., Peng N., Oliveira-dos-Santos A., Penninger J.M., Muslin A.J., Steinberg T.H., Wyss J.M., Mecham R.P., Blumer K.J. Hypertension and prolonged vasoconstrictor signalling in RGS2-deficient mice. J. Clin. Invest. 2003;111:445–452. doi: 10.1172/JCI15598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chen C.K., Burns M.E., He W., Wensel T.G., Baylor D.A., Simon M.I. Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature. 2000;403:557–560. doi: 10.1038/35000601. [DOI] [PubMed] [Google Scholar]
  • 13.Fu Y., Huang X., Piao L., Lopatin A.N., Neubig R.R. Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block. Am. J. Physiol. Heart Circ. Physiol. 2007;292:H2532–2539. doi: 10.1152/ajpheart.01391.2006. [DOI] [PubMed] [Google Scholar]
  • 14.Hurst J.H., Henkel P.A., Brown A.L., Hooks S.B. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signalling pathways in ovarian cancer cells. Cell. Signal. 2008;20:381–389. doi: 10.1016/j.cellsig.2007.10.026. [DOI] [PubMed] [Google Scholar]
  • 15.Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 16.Hepler J.R., Nakahata N., Lovenberg T.W., DiGuiseppi J., Herman B., Earp H.S., Harden T.K. Epidermal growth factor stimulates the rapid accumulation of inositol (1,4,5)-trisphosphate and a rise in cytosolic calcium mobilized from intracellular stores in A431 cells. J. Biol. Chem. 1987;262:2951–2956. [PubMed] [Google Scholar]
  • 17.Hollinger S., Hepler J.R. Cellular regulation of RGS proteins: modulators and integrators of G protein signalling. Pharmacol. Rev. 2002;54:527–559. doi: 10.1124/pr.54.3.527. [DOI] [PubMed] [Google Scholar]
  • 18.Chatterjee T.K., Liu Z., Fisher R.A. Human RGS6 gene structure, complex alternative splicing, and role of N terminus and G protein gamma-subunit-like (GGL) domain in subcellular localization of RGS6 splice variants. J. Biol. Chem. 2003;278:30261–30271. doi: 10.1074/jbc.M212687200. [DOI] [PubMed] [Google Scholar]
  • 19.Fukushima N., Kimura Y., Chun J. A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl. Acad. Sci. USA. 1998;95:6151–6156. doi: 10.1073/pnas.95.11.6151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ishii I., Contos J.J., Fukushima N., Chun J. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol. Pharmacol. 2000;58:895–902. doi: 10.1124/mol.58.5.895. [DOI] [PubMed] [Google Scholar]
  • 21.Contos J.J., Ishii I., Chun J. Lysophosphatidic acid receptors. Mol. Pharmacol. 2000;58:1188–1196. doi: 10.1124/mol.58.6.1188. [DOI] [PubMed] [Google Scholar]
  • 22.Lee C.W., Rivera R., Dubin A.E., Chun J. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signalling and G(12/13)-mediated Rho activation. J. Biol. Chem. 2007;282:4310–4317. doi: 10.1074/jbc.M610826200. [DOI] [PubMed] [Google Scholar]
  • 23.Waldo G.L., Boyer J.L., Morris A.J., Harden T.K. Purification of an AlF4- and G-protein beta gamma-subunit-regulated phospholipase C-activating protein. J. Biol. Chem. 1991;266:14217–14225. [PubMed] [Google Scholar]
  • 24.Boyer J.L., Waldo G.L., Harden T.K. Beta gamma-subunit activation of G-protein-regulated phospholipase C. J. Biol. Chem. 1992;267:25451–25456. [PubMed] [Google Scholar]
  • 25.Hains M.D., Wing M.R., Maddileti S., Siderovski D.P., Harden T.K. Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors. Mol. Pharmacol. 2006;69:2068–2075. doi: 10.1124/mol.105.017921. [DOI] [PubMed] [Google Scholar]
  • 26.Chen C.K., Eversole-Cire P., Zhang H., Mancino V., Chen Y.J., He W., Wensel T.G., Simon M.I. Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5. Proc. Natl. Acad. Sci. USA. 2003;100:6604–6609. doi: 10.1073/pnas.0631825100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ujioka T., Russell D.L., Okamura H., Richards J.S., Espey L.L. Expression of regulator of G-protein signalling protein-2 gene in the rat ovary at the time of ovulation. Biol. Reprod. 2000;63:1513–1517. doi: 10.1095/biolreprod63.5.1513. [DOI] [PubMed] [Google Scholar]
  • 28.Heximer S.P., Watson N., Linder M.E., Blumer K.J., Hepler J.R. RGS2/G0S8 is a selective inhibitor of Gqalpha function. Proc. Natl. Acad. Sci. USA. 1997;94:14389–14393. doi: 10.1073/pnas.94.26.14389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Heximer S.P., Srinivasa S.P., Bernstein L.S., Bernard J.L., Linder M.E., Hepler J.R., Blumer K.J. G protein selectivity is a determinant of RGS2 function. J. Biol. Chem. 1999;274:34253–34259. doi: 10.1074/jbc.274.48.34253. [DOI] [PubMed] [Google Scholar]
  • 30.Ingi T., Krumins A.M., Chidiac P., Brothers G.M., Chung S., Snow B.E., Barnes C.A., Lanahan A.A., Siderovski D.P., Ross E.M., Gilman A.G., Worley P.F. Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signalling and neuronal plasticity. J. Neurosci. 1998;18:7178–7188. doi: 10.1523/JNEUROSCI.18-18-07178.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tosetti P., Parente V., Taglietti V., Dunlap K., Toselli M. Chick RGS2L demonstrates concentration-dependent selectivity for pertussis toxin-sensitive and -insensitive pathways that inhibit L-type Ca2+ channels. J. Physiol. 2003;549:157–169. doi: 10.1113/jphysiol.2002.034439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.De Vries L., Mousli M., Wurmser A., Farquhar M.G. GAIP, a protein that specifically interacts with the trimeric G protein G alpha i3, is a member of a protein family with a highly conserved core domain. Proc. Natl. Acad. Sci. USA. 1995;92:11916–11920. doi: 10.1073/pnas.92.25.11916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hepler J.R., Berman D.M., Gilman A.G., Kozasa T. RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha. Proc. Natl. Acad. Sci. USA. 1997;94:428–432. doi: 10.1073/pnas.94.2.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Berman D.M., Wilkie T.M., Gilman A.G. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell. 1996;86:445–452. doi: 10.1016/S0092-8674(00)80117-8. [DOI] [PubMed] [Google Scholar]
  • 35.Huang C., Hepler J.R., Gilman A.G., Mumby S.M. Attenuation of Gi-and Gq-mediated signalling by expression of RGS4 or GAIP in mammalian cells. Proc. Natl. Acad. Sci. USA. 1997;94:6159–6163. doi: 10.1073/pnas.94.12.6159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hooks S.B., Waldo G.L., Corbitt J., Bodor E.T., Krumins A.M., Harden T.K. RGS6, RGS7, RGS9, and RGS11 stimulate GTPase activity of Gi family G-proteins with differential selectivity and maximal activity. J. Biol. Chem. 2003;278:10087–10093. doi: 10.1074/jbc.M211382200. [DOI] [PubMed] [Google Scholar]
  • 37.Seki N., Hattori A., Hayashi A., Kozuma S., Hori T., Saito T. The human regulator of G-protein signalling protein 6 gene (RGS6) maps between markers WI-5202 and D14S277 on chromosome 14q24.3. J. Hum. Genet. 1999;44:138–140. doi: 10.1007/s100380050129. [DOI] [PubMed] [Google Scholar]
  • 38.Gunthert A.R., Grundker C., Bottcher B., Emons G. Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells. Anticancer Res. 2004;24:1727–1732. [PubMed] [Google Scholar]
  • 39.Lee Z., Swaby R.F., Liang Y., Yu S., Liu S., Lu K.H., Bast R.C., Jr., Mills G.B., Fang X. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Cancer Res. 2006;66:2740–2748. doi: 10.1158/0008-5472.CAN-05-2947. [DOI] [PubMed] [Google Scholar]
  • 40.Choi J.H., Choi K.C., Auersperg N., Leung P.C. Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells. Cancer Res. 2006;66:3912–3920. doi: 10.1158/0008-5472.CAN-05-1785. [DOI] [PubMed] [Google Scholar]

Articles from Cellular & Molecular Biology Letters are provided here courtesy of BMC

RESOURCES